TriSalus Life Sciences In... (TLSI)
NASDAQ: TLSI
· Real-Time Price · USD
3.88
-0.07 (-1.77%)
At close: Aug 14, 2025, 3:59 PM
3.81
-1.80%
After-hours: Aug 14, 2025, 05:54 PM EDT
-1.77% (1D)
| Bid | 3.34 |
| Market Cap | 147.35M |
| Revenue (ttm) | 32.14M |
| Net Income (ttm) | -27.21M |
| EPS (ttm) | -1.15 |
| PE Ratio (ttm) | -3.37 |
| Forward PE | -23.29 |
| Analyst | Buy |
| Ask | 4.2 |
| Volume | 28,355 |
| Avg. Volume (20D) | 104,795.6 |
| Open | 3.80 |
| Previous Close | 3.95 |
| Day's Range | 3.69 - 4.00 |
| 52-Week Range | 3.42 - 6.03 |
| Beta | 0.48 |
About TLSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TLSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TLSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
TriSalus Life Sciences has released their quartely earnings
on Aug 12, 2025:
Next Earnings Release
TriSalus Life Sciences Inc. is scheduled to release its earnings on
Nov 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
-10.89%
TriSalus Life Sciences shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago · businesswire.com
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion SystemDENVER--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative deli...
